Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In our projects we aim to characterize the systemic, intestinal and liver immune response in patients with PSC and IBD through a combination of high throughput techniques, including multicolour flow cytometry, CyTOF mass cytometry, molecular biology and in situ analysis. Furthermore, we are using state-of-the-art whole genome shotgun sequencing to investigate both microbiome and patients intestinal transcriptomes and identify novel pathways through which microbial products can influence the host immune function.


This is what we are focusing on right now:

  • Characterization of the mucosal and systemic immune response in patients with IBD and PSC
  • Analysis of the microbiome-host interaction in PSC-IBD using whole genome shotgun sequencing
  • Investigating the gut-vascular barrier in patients with IBD and PSC